Biostem Technologies Inc (BSEM)

Currency in USD
2.8801
-0.9199(-24.21%)
Real-time Data·
Advertisement
Unusual trading volume
Trading near 52-week Low
BSEM is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
2.25103.1000
52 wk Range
2.251010.6500
Key Statistics
Prev. Close
3.8
Open
2.3
Day's Range
2.251-3.1
52 wk Range
2.251-10.65
Volume
330.39K
Average Volume (3m)
59.99K
1-Year Change
-73.0214%
Book Value / Share
1.88
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
BSEM Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
7.0000
Upside
+143.05%
Members' Sentiments
Bearish
Bullish
ProTips
Impressive gross profit margins

Biostem Technologies Inc News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Strong Sell

Analyst Ratings

1 Buy
0 Hold
0 Sell
Ratings:
1 analysts
Overall Consensus
Strong Buy

Analysts 12-Month Price Target:

Average 7.0000
(+143.05% Upside)
Firm
ArticlePositionPrice TargetUpside / DownsideFrom Price TargetActionDate
H.C. Wainwright
Buy7.00+129.74%9.00Maintain18/05/2026
H.C. Wainwright
Sell9.00+195.38%-New Coverage06/05/2026

Biostem Technologies Inc Earnings Call Summary for Q2/2026

  • BioStem posted Q2 2026 loss of $0.52/share on $7.9M revenue, missing estimates of $0.08 loss on $11M revenue; shares rose 10.8% on raised guidance.
  • Company raised FY 2026 revenue guidance to $26M-$29M from $25M-$29M, citing hospital-channel growth which now represents 85% of business.
  • Sequential revenue grew 29.5% from Q1's $6.1M; gross margin held at 61%, expected to reach 70%+ after in-house manufacturing transition in H1 2027.
  • Cash declined to $7.0M from $13.7M with $5.5M quarterly burn; firm evaluating non-dilutive financing for $10M contingent payment liability.
  • Management expects flat operating expenses through 2026, first 510(k) clearance this year, and continued hospital sales expansion to 40+ reps by year-end.
Last Updated: 12/08/2026, 22:16
Read Full Transcript

Earnings

Latest Release
12/08/2026
EPS / Forecast
-0.52 / -0.08
Revenue / Forecast
7.9M / 11M
EPS Revisions
Last 90 days

Compare BSEM to Peers and Sector

Metrics to compare
BSEM
Peers
Sector
Relationship
P/E Ratio
−3.5x−1.1x−0.3x
PEG Ratio
0.020.070.00
Price/Book
2.1x0.4x2.6x
Price / LTM Sales
1.8x3.2x3.1x
Upside (Analyst Target)
84.2%32.9%48.3%
Fair Value Upside
Unlock9.2%6.7%Unlock

BioStem Technologies, Inc. engages in the development, manufacturing, and commercialization of placental-derived allografts for advanced wound care and regenerative therapies in the United States. It offers Vendaje, a human connective tissue matrix compromised of amniotic tissue intended for wound covering; Vendaje AC, a thicker structural tissue allograft used as a protective covering for soft tissue wounds; Vendaje OPTIC, a structural tissue allograft used as a protective covering during the repair of ocular surfaces; American Amnion AC, a human connective tissue matrix for homologous use; and American Amnion, a human connective tissue matrix for homologous use. The company was formerly known as Caribbean International Holdings Inc. and changed its name to BioStem Technologies, Inc. in August 2014. BioStem Technologies, Inc. was incorporated in 2006 and is based in Fort Lauderdale, Florida.

Employees
73

Ownership

Ownership Overview

Type
Common Stock Held% of Shares OutstandingMarket Value
Mutual Funds & ETFs
351.000.00%1.33K
Other Institutional Investors
0.000.00%0.00
Public Companies & Retail Investors
17.73M100.00%67.36M
Total
17.73M100.00%67.36M

Top Holders

Holder
% of holding
Shares Held
Date Reported
Value (In 1,000s)
Lumyna Investments Limited0.00%3511
Lumyna-Marshall Wace UCITS SICAV - Lumyna-MW Tops UCITS Fund0.00%3511

People Also Watch

8.490
TRAK
+1.19%
7.72
MHH
-1.91%
46.03
ANDG
-7.94%
3.100
SILO
+0.16%

FAQ

What Is the Biostem Tech (NASDAQ: BSEM) Share Price Today?

The Biostem Tech stock price today is 2.8801 USD.

What Stock Exchange Does Biostem Tech (BSEM) Trade On?

Biostem Tech is listed and trades on the Nasdaq Stock Exchange.

What Is the Ticker (Stock Symbol) for Biostem Tech?

The stock symbol (also called a 'ticker') for Biostem Tech is "BSEM."

What Is the Current Biostem Tech Market Capitalisation?

As of today, Biostem Tech (NASDAQ: BSEM) market cap is 67.3600M USD.

What Is Biostem Tech's (BSEM) Earnings Per Share (TTM)?

The Biostem Tech EPS is currently -1.1512 (Trailing Twelve Months).

When Is the Next Biostem Tech Earnings Date?

Biostem Tech's next earnings report will be released on 17/11/2026.

Is BSEM a Buy or Sell From a Technical Analyst Perspective?

Based on today's Biostem Tech moving averages and other technical indicators, the daily buy/sell signal for BSEM stock is Strong Sell.

How Many Times Has Biostem Tech Stock Split?

Biostem Tech has split 5 times. (See the BSEM stock split history page for full effective split date and price information.)

How Many Employees Does Biostem Tech Have?

Biostem Tech has 73 employees, based on their latest Companies House report.

What is the current trading status of Biostem Tech (NASDAQ: BSEM)?

As of 13/08/2026, Biostem Tech (BSEM) is trading at a share price of 2.8801 USD, with a previous close of 3.8000 USD. The stock has fluctuated within a day range of 2.2510 USD to 3.1000 USD, while its 52-week range spans from 2.2510 USD to 10.6500 USD.

What Is Biostem Tech (BSEM) Price Target According to Analysts?

The average 12-month price target for Biostem Tech is 7.0000 USD, with a high estimate of 7 USD and a low estimate of 7 USD. 1 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Strong Buy. The stock has an +143.05% Upside potential.

What Is the BSEM Premarket Price?

BSEM's last pre-market stock price is 2.4400 USD. The pre-market share volume is 49,890.0000, and the stock has decreased by -1.3600, or -35.7900%.

What Is the BSEM After Hours Price?

BSEM's last after hours stock price is 3.8500 USD, the stock has decreased by 0.0500, or 1.3200%.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.